Latest Shareholder Equity News

EV Resources has partnered with U.S.-based MineMaker LLC to accelerate its antimony projects in Mexico and Nevada, aiming to become a key supplier to North America’s critical minerals market.

Marimaca Copper has successfully raised C$409 million through a dual Canadian and Australian equity offering, positioning the company to advance its flagship Marimaca Project and exploration at Pampa Medina.

Stavely Minerals has locked in a $500,000 unsecured director loan facility to fund its 2026 Scoping Study targeting copper, gold, and silver production. This non-dilutive funding move underscores confidence from within the board as the company advances key projects.

Deterra Royalties Limited has announced a fully franked ordinary dividend of AUD 0.124 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a no-discount option to reinvest.

Swoop Holdings has completed the placement of its entitlement offer shortfall, raising an additional $0.7 million and bringing total proceeds to $10 million. Notably, non-executive directors have subscribed for half of the shortfall shares, pending shareholder approval.

WAM Leaders Limited has announced a fully franked ordinary dividend of 4.8 cents per share for the half-year ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Origin Energy has announced a fully franked dividend of AUD 0.30 per share for the six months ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.

BKI Investment Company Limited reported a 10% rise in net profit after tax for the half year ended December 2025, alongside a modest dividend increase and a strategic portfolio rotation favouring resources and energy transition themes.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.

Everest Metals Corporation has ramped up mining operations at its Mt Dimer Taipan Gold Project, delivering over 25,000 tonnes of ore and initiating a major drilling program to expand resources and optimise production.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.